100K Genomes Project

Articles

A bold initiative aimed at making the NHS a world leader in 'precision medicine', England's 100K Genomes Project is advancing rapidly.

News

Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.